Form 4: Enact Holdings EVP Sells 9,000 Shares
Insider Transaction Report
Enact Holdings' EVP and Chief Risk Officer, Michael Derstine, sold 9,000 shares of common stock for a weighted average price of $42.213 per share.
Summary
- Michael Derstine, Executive Vice President and Chief Risk Officer of Enact Holdings, Inc. (ACT), disposed of 9,000 shares of common stock.
- The transaction occurred on March 2, 2026, at a weighted average sale price of $42.213 per share.
- The sale price ranged from $42.09 to $42.25 per share.
- Following this transaction, Michael Derstine directly beneficially owns 39,104 shares of Enact Holdings common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a slightly negative development due to insider selling, although the presence of a 10b5-1 plan somewhat mitigates the immediate negative implications.
Positives
- The sale was conducted under a Rule 10b5-1 plan, indicating a pre-arranged transaction not necessarily based on new, non-public information.
Negatives
- An insider, specifically the Chief Risk Officer, selling a notable portion of their holdings (approximately 18.75% of pre-transaction shares) can be perceived as a negative signal by the market, potentially indicating a lack of confidence or a move to diversify.
Risks
- Insider selling, particularly by a key executive, may lead to negative market sentiment and potential downward pressure on the stock price.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider transactions, especially sales by high-ranking executives like a Chief Risk Officer, are closely watched by investors as they can sometimes signal management's perception of the company's future prospects. While a 10b5-1 plan mitigates the immediate implication of trading on new information, the act of selling itself can still influence market sentiment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Disclosure | The transaction was executed pursuant to a Rule 10b5-1(c) plan, which allows insiders to set up a pre-arranged schedule for buying or selling company stock to avoid accusations of insider trading. | 03/02/2026 | This indicates a structured approach to stock sales, reducing concerns about opportunistic trading based on undisclosed material information, but does not negate the signal of an insider reducing their stake. |
Stakeholder Impact
- Shareholders may interpret the insider sale as a signal of reduced confidence in the company's future prospects, potentially leading to negative sentiment and selling pressure on the stock.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of transaction where 9,000 shares were disposed. |
| 03/04/2026 | Date the Form 4 filing was signed. |
Recommendation
holdWhile insider selling by a key executive is generally a negative signal, the transaction being executed under a Rule 10b5-1 plan suggests it was pre-scheduled and not necessarily driven by new, adverse information. Given this context and without further information on the company's fundamentals or a pattern of widespread insider selling, a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance closely.
Keywords
Enact Holdings, ACT, Insider Sale, Form 4, Michael Derstine, Chief Risk Officer, Equity Transaction, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.